Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 5:30 PM View:  | Hooks Corwin Dale Chief Commercial Officer | Applied Therapeutics, Inc. (APLT) | 12-Apr-24 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K | |
| 18-Mar-24 6:00 PM View: | Hansard Adam Chief Commercial Officer | Applied Therapeutics, Inc. (APLT) | 14-Mar-24 | Private Sale | 48,871 | $5.39 | $263,415.00 | (6%) 781.79K to 732.92K | |
| 18-Mar-24 6:12 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 14-Mar-24 | Private Sale | 318,573 | $5.39 | $1,717,110.00 | (4%) 8.47M to 8.15M | |
| 18-Mar-24 6:02 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 14-Mar-24 | Private Sale | 110,804 | $5.39 | $597,234.00 | (10%) 1.14M to 1.03M | |
| 18-Mar-24 5:57 PM View: | Funtleyder Leslie D. Chief Financial Officer Director | Applied Therapeutics, Inc. (APLT) | 14-Mar-24 | Private Sale | 28,727 | $5.39 | $154,839.00 | (9%) 337.15K to 308.42K | |
| 18-Mar-24 5:51 PM View: | Chinoporos Constantine See Remarks | Applied Therapeutics, Inc. (APLT) | 28-Dec-23 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K | |
| 22-Dec-23 8:01 PM View: | Hansard Adam Chief Commercial Officer | Applied Therapeutics, Inc. (APLT) | 21-Dec-23 | Grant | 400,000 | -- | -- | 105% 381.79K to 781.79K | |
| 22-Dec-23 8:01 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 21-Dec-23 | Grant | 1,540,000 | -- | -- | 22% 6.93M to 8.47M | |
| 22-Dec-23 8:01 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 21-Dec-23 | Grant | 450,000 | -- | -- | 65% 692.34K to 1.14M | |
| 05-Dec-23 7:03 PM View: | Kanter Stacy J. Director | Applied Therapeutics, Inc. (APLT) | 01-Dec-23 | Private Purchase | 30,000 | $2.18 | $65,367.00 | 91% 33.0K to 63.0K | |
| 01-Dec-23 7:42 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 30-Nov-23 | Sale | 1,583 | $1.97 | $3,118.51 | (< 1%) 693.92K to 692.34K | |
| 01-Dec-23 7:42 PM View: | Hansard Adam Chief Commercial Officer | Applied Therapeutics, Inc. (APLT) | 30-Nov-23 | Sale | 965 | $1.97 | $1,901.05 | (< 1%) 382.75K to 381.79K | |
| 01-Dec-23 7:42 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 30-Nov-23 | Sale | 3,968 | $1.97 | $7,816.96 | (< 1%) 6.93M to 6.93M | |
| 01-Dec-23 6:53 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 29-Nov-23 | Acquisition (other) | 575,000 | -- | -- | 9% 6.36M to 6.93M | |
| 01-Dec-23 6:53 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 29-Nov-23 | Disposition (other) | 575,000 | -- | -- | (8%) 6.93M to 6.36M | |
| 20-Nov-23 4:41 PM View: | Funtleyder Leslie D. Chief Financial Officer Director | Applied Therapeutics, Inc. (APLT) | 20-Nov-23 | Grant | 300,000 | -- | -- | 808% 37.15K to 337.15K | |
| 06-Nov-23 4:56 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 03-Nov-23 | Sale | 143,450 | $2.31 | $331,370.00 | (2%) 6.5M to 6.36M | |
| 06-Nov-23 4:56 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 02-Nov-23 | Sale | 103,808 | $2.32 | $240,835.00 | (2%) 6.61M to 6.5M | |
| 02-Nov-23 4:44 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 01-Nov-23 | Sale | 172,742 | $2.36 | $407,671.00 | (3%) 6.78M to 6.61M | |
| 02-Nov-23 4:44 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 31-Oct-23 | Sale | 155,000 | $2.41 | $373,550.00 | (2%) 6.93M to 6.78M | |
| 16-Oct-23 7:17 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 12-Oct-23 | Acquisition (other) | 1,600,000 | -- | -- | 23% 6.93M to 8.53M | |
| 16-Oct-23 7:17 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 12-Oct-23 | Disposition (other) | 1,600,000 | -- | -- | (19%) 8.53M to 6.93M | |
| 29-Sep-23 8:02 PM View: | Hansard Adam Chief Commercial Officer | Applied Therapeutics, Inc. (APLT) | 27-Sep-23 | Sale | 9,720 | $2.70 | $26,244.00 | (2%) 392.48K to 382.75K | |
| 29-Sep-23 8:03 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 27-Sep-23 | Sale | 115,632 | $2.70 | $312,206.00 | (2%) 7.05M to 6.93M | |
| 29-Sep-23 8:02 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 27-Sep-23 | Sale | 10,932 | $2.70 | $29,516.40 | (2%) 704.86K to 693.92K | |
| 19-Sep-23 8:08 PM View: | Marcus Joel S Director | Applied Therapeutics, Inc. (APLT) | 15-Sep-23 | Option Exercise | 12,375 | $1.05 | $12,993.70 | 3% 441.04K to 453.41K | |
| 08-Jun-23 9:03 PM View: | Marcus Joel S Director | Applied Therapeutics, Inc. (APLT) | 06-Jun-23 | Grant | 20,000 | -- | -- | 5% 421.04K to 441.04K | |
| 08-Jun-23 9:02 PM View: | Lerner Teena Director | Applied Therapeutics, Inc. (APLT) | 06-Jun-23 | Grant | 20,000 | -- | -- | 49% 40.42K to 60.42K | |
| 08-Jun-23 9:03 PM View: | Skyler Jay S Director | Applied Therapeutics, Inc. (APLT) | 06-Jun-23 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 08-Jun-23 9:01 PM View: | Funtleyder Leslie D. Director | Applied Therapeutics, Inc. (APLT) | 06-Jun-23 | Grant | 20,000 | -- | -- | 117% 17.15K to 37.15K | |
| 08-Jun-23 9:02 PM View: | Kanter Stacy J. Director | Applied Therapeutics, Inc. (APLT) | 06-Jun-23 | Grant | 20,000 | -- | -- | 154% 13.0K to 33.0K | |
| 13-Jan-23 4:32 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 11-Jan-23 | Sale | 6,053 | $0.91 | $5,508.23 | (< 1%) 710.91K to 704.86K | |
| 13-Jan-23 4:30 PM View: | Hansard Adam Chief Commercial Officer | Applied Therapeutics, Inc. (APLT) | 11-Jan-23 | Grant | 300,000 | -- | -- | 309% 96.97K to 396.97K | |
| 13-Jan-23 4:34 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 11-Jan-23 | Grant | 1,964,360 | -- | -- | 39% 5.1M to 7.06M | |
| 13-Jan-23 4:30 PM View: | Hansard Adam Chief Commercial Officer | Applied Therapeutics, Inc. (APLT) | 11-Jan-23 | Sale | 4,495 | $0.91 | $4,090.45 | (1%) 396.97K to 392.48K | |
| 13-Jan-23 4:32 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 11-Jan-23 | Grant | 550,000 | -- | -- | 342% 160.91K to 710.91K | |
| 13-Jan-23 4:34 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 11-Jan-23 | Sale | 15,870 | $0.91 | $14,441.70 | (< 1%) 7.06M to 7.05M | |
| 17-Nov-22 9:31 PM View: | Ortega Steven A. Principal Accounting Officer | Applied Therapeutics, Inc. (APLT) | 15-Nov-22 | Grant | 40,000 | -- | -- | 260% 15.4K to 55.4K | |
| 14-Oct-22 5:41 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 14-Oct-22 | Private Purchase | 50,000 | $0.64 | $32,250.00 | < 1% 5.05M to 5.1M | |
| 13-Oct-22 6:17 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 13-Oct-22 | Private Purchase | 73,256 | $0.56 | $40,891.50 | 1% 4.97M to 5.05M | |
| 12-Oct-22 8:51 PM View: | Shendelman Shoshana President and CEO Director 10% Owner | Applied Therapeutics, Inc. (APLT) | 12-Oct-22 | Private Purchase | 38,153 | $0.52 | $19,942.60 | < 1% 4.94M to 4.97M | |
| 16-Sep-22 9:01 PM View: | Marcus Joel S Director | Applied Therapeutics, Inc. (APLT) | 14-Sep-22 | Option Exercise | 38,244 | $1.05 | $40,156.20 | 10% 382.8K to 421.04K | |
| 29-Jun-22 4:37 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 27-Jun-22 | Private Purchase | 3,500,000 | $1.00 | $3,500,000.00 | 102% 3.43M to 6.93M | |
| 18-May-22 9:03 PM View: | Mahadevan Chids See Remarks | Applied Therapeutics, Inc. (APLT) | 16-May-22 | Sale | 905 | $1.65 | $1,493.25 | (8%) 10.71K to 9.8K | |
| 15-Apr-22 7:09 PM View: | Ortega Steven A. Principal Accounting Officer | Applied Therapeutics, Inc. (APLT) | 13-Apr-22 | Grant | 3,081 | -- | -- | 25% 12.32K to 15.4K | |
| 15-Apr-22 7:08 PM View: | Mahadevan Chids See Remarks | Applied Therapeutics, Inc. (APLT) | 13-Apr-22 | Grant | 2,136 | -- | -- | 25% 8.57K to 10.71K | |
| 23-Mar-22 9:00 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 23-Mar-22 | Purchase | 30,000 | $1.97 | $59,100.00 | 23% 130.91K to 160.91K | |
| 23-Mar-22 9:00 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 22-Mar-22 | Purchase | 21,961 | $1.98 | $43,482.80 | 20% 108.95K to 130.91K | |
| 23-Mar-22 9:00 PM View: | Perfetti Riccardo Chief Medical Officer | Applied Therapeutics, Inc. (APLT) | 21-Mar-22 | Private Purchase | 12,548 | $1.85 | $23,213.80 | 13% 96.4K to 108.95K | |
| 25-Feb-22 10:00 PM View: | Alexandria Real Estate Equi... 10% Owner | Applied Therapeutics, Inc. (APLT) | 23-Feb-22 | Acquisition (other) | 300,000 | -- | -- | 9% 3.43M to 3.73M |
